- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
Tuesday, the Virginia Senate passed SB701: Cannabidiol (CBD) oil and THC-A oil; permitting of pharmaceutical processors to manufacture and provide. Now, we need your help to get this passed in the House of Delegates.
Last year’s passage of SB1235 and HB1445 provided an affirmative defense to the patients and caregivers diagnosed with intractable epilepsy who use Cannabidiol and THC-A, both non-psychoactive oils derived from the cannabis plant. The results have been nothing short of miraculous for these patients with decreases in seizures, cognitive gains, and the ability to wean pharmaceuticals that cause horrible side-effects.
However, these patients and their caregivers are having to break state and federal laws in order to obtain these oils putting them at great risk, and many of Virginia’s epilepsy patients have not been able to get access to this treatment.
This bill, if passed, would be the first step for these patients as it would require the Board of Pharmacy to develop and then implement detailed guidelines for responsible and tightly controlled production and distribution of these oils. The 27,000 patients with intractable epilepsy living in the state of Virginia, and the 1,000 Virginians who die each year due to uncontrolled seizures deserve this chance.
Please help Virginia move forward on this important issue.
Take Action Now!